We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PKG:NYSEPackaging Corporation of America Analysis

Data as of 2026-03-10 - not real-time

$221.32

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Packaging Corporation of America is trading at $221.32, comfortably above its 200‑day SMA of $208 but below both the 20‑day ($233.5) and 50‑day ($225.1) averages, suggesting a short‑term pullback within a longer‑term bullish framework. The RSI of 38.4 hints at near‑oversold conditions, yet the MACD remains bearish with a negative histogram, and volume has been tapering, placing the stock close to its technical support at $214.5. Market sentiment is extremely optimistic – the Fear & Greed Index reads 76.9 (“Extreme Greed”) – but the 30‑day volatility of 26.7% and a recent max drawdown of almost 13% underscore a non‑trivial risk profile.
Fundamentally, PKG posted a 10% revenue surge, EPS growth from $8.58 to an estimated $12.21, and a respectable ROE of 17%, supporting its buy consensus among ten analysts. However, a high debt‑to‑equity ratio near 95%, a P/E of 25.8, and a DCF‑derived fair value of $56.4 signal significant overvaluation, while the 2.24% dividend yield with a 58% payout appears sustainable given solid operating cash flow.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering near technical support at $214.5
  • Bearish MACD and decreasing volume
  • RSI approaching oversold territory

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth of 10% and rising forward EPS
  • Analyst consensus of "buy" with target median $234.5
  • Sustainable dividend yield of 2.24%

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • DCF fair value far below current price indicating overvaluation
  • High debt‑to‑equity ratio adding balance‑sheet risk
  • Cyclical exposure of the consumer packaging sector

Key Metrics & Analysis

Financial Health

Revenue Growth10.10%
Profit Margin8.61%
P/E Ratio25.8
ROE17.20%
ROA8.30%
Debt/Equity94.93
P/B Ratio4.3
Op. Cash Flow$1.6B
Free Cash Flow$414.6M

Technical Analysis

TrendBullish
RSI38.4
Support$214.52
Resistance$249.51
MA 20$233.53
MA 50$225.06
MA 200$208.04
MACDBearish
VolumeDecreasing
Fear & Greed Index76.91

Valuation

Fair Value$56.44
Target Price$231.90
Upside/Downside4.78%
GradeOvervalued
TypeGrowth
Dividend Yield2.24%

Risk Assessment

Beta0.78
Volatility26.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.